Live Feeds
● LIVE Updated 1h ago · 5 sources tracked

The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round

Medical search and clinical intelligence platform OpenEvidence achieved a $15 billion valuation following a new alternative financing round. The company, often described as a ChatGPT for doctors, secured $250 million in the recent transaction. Andreessen Horowitz and Byers Capital led the financing effort for the medical tech platform. The fresh capital influx highlights the rapid commercial growth and investor appetite for artificial intelligence tools tailored specifically to clinical professionals and healthcare providers.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~2 min
Speed:
RSS Source map (5)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ OpenEvidence secured a valuation of $15 billion in a new alternative financing round.
  • ✓ The company reportedly raised $250 million in the financing round.
  • ✓ Andreessen Horowitz and Byers Capital led the financing round.
🛡️ Source Corroboration: 5 independent reporting domains (100% confidence) ⏱ Read time: ~2 min

What changed

OpenEvidence secured $250 million in alternative financing, bringing its valuation to $15 billion.

Live updates

  1. OpenEvidence Valued at $15 Billion in Funding Round

    Medical search and clinical intelligence platform OpenEvidence achieved a $15 billion valuation following a new alternative financing round. The company, often described as a ChatGPT for doctors, secured $250 million in the recent transaction. Andreessen Horowitz and Byers Capital led the financing effort for the medical tech platform. The fresh capital influx highlights the rapid commercial growth and investor appetite for artificial intelligence tools tailored specifically to clinical professionals and healthcare providers.

    Why it matters

    The massive funding round underscores the rising demand for specialized medical artificial intelligence systems designed to assist physicians in clinical workflows. OpenEvidence operates as a tool for medical professionals to find evidence-based clinical information quickly. The participation of prominent venture capital firms like Andreessen Horowitz and Byers Capital reflects strong backing for medical technology infrastructure.

    What is confirmed

    • OpenEvidence secured a valuation of $15 billion in a new alternative financing round.
    • The company reportedly raised $250 million in the financing round.
    • Andreessen Horowitz and Byers Capital led the financing round.

    What to watch next

    • Further details regarding the deployment of the $250 million in capital
    • Potential expansion of OpenEvidence clinical AI products and enterprise partnerships
    Sources used for this update (5)
    1. businessinsider.com — The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round
    2. Axios — OpenEvidence reportedly raises $250M at $15B valuation
    3. healthcare.digital — OpenEvidence secures $250 Million alternative financing round led by Andreessen Horowitz and Byers Capital at $15 Billion valuation
    4. Digital Health Wire — OpenEvidence’s Quiet Raise and Loud Pivot
    5. TradingView — OpenEvidence Was Valued At $15 Billion In A New Funding Round - Business Insider
    confidence 100%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community